PurposeBio is a Deep-Tech SynBio Platform, pre-clinical phase, advancing proprietary, groundbreaking science and developing Therapeutics for Cardiometabolic Disease with Unmet Needs. We aim to positively affect the health and lives of at least 1 in 2 of the world's human population. Our team is built from the world's leaders in SynBio Research and Computer Science and our Science is based on world class academic institutions. We spin out technology from UCLA and were named "The Best, Most Investment-Worthy Startup of 2022" by UCLA.
| Website | http://www.purposebio.com |
| Employees | 6 (4 on RocketReach) |
| Founded | 2020 |
| Technologies |
JavaScript
,
HTML
,
Twitter
+7 more
(view full list)
|
| Industry | Biotechnology Research |
| Competitors | Amgen, Corteva Agriscience, Geno, Novozymes, Zymergen, Inc., Ceres Global Ag Corp., Amyris, Arzeda, Biosyntia, Ecovative Spawn & Substrate - formerly Lambert Spawn Europa +31 more (view full list) |
Looking for a particular PurposeBio employee's phone or email?
Lital Gilad-Shaoulian is the CEO, Founder of PurposeBio.
4 people are employed at PurposeBio.
PurposeBio is based in Los Angeles, California.